The Use of Caffeine Citrate for Respiratory Stimulation in Acquired Central Hypoventilation Syndrome: A Case Series
References
- Schläfke ME, Pokorski M, See WR, Prill RK, Loeschcke HH. Chemosensitive neurons on the ventral medullary surface. Bull Physiopathol Respir (Nancy). 1975;11(2):277–84.
- Demartini Junior Z, Gatto LAM, Koppe GL, Francisco AN, Guerios EE. Ondine’s curse: myth meets reality. Sleep Med: X 2. 2020;100012.
- Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006; 117(6):1979-87.
- Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–21.
- Dobson NR, Hunt CE. Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. NeoReviews. 2003;14;e540-50.
- Bellingham MC. Driving respiration: the respiratory central pattern generator. Clin Exp Pharmacol Physiol. 1998;25(10):847-56.
- Piper AJ, Yee BJ. Hypoventilation syndromes. Compr Physiol. 2014;4(4):1639-76.
- Schrader L, Horsfall J, Bookheimer S. Use of caffeine during intraoperative awake language mapping. J Clin Neurophysiol. 2011;28(4):424–9.
- Gouda NM. Intravenous caffeine for adult patients with obstructive sleep apnea undergoing uvulopalatopharyngoplasty: effects on postoperative respiratory complications and recovery profile. Med J Cairo Univ. 2010;78:155–9.
- Warner NS, Warner MA, Schroeder DR, Sprung J, Weingarten TN. Effects of caffeine administration on sedation and respiratory parameters in patients recovering from anesthesia. Bosn J Basic Med Sci. 2018 Feb; 18(1): 101–104.
- Fong R, Wang L, Zacny JP, Khokhar S, Apfelbaum JL, Fox AP, et al. Caffeine accelerates emergence from Isoflurane anesthesia in humans: a randomized, double-blind, crossover study. Anesthesiol. 2018;129(5):912–20.
- Lexi-drugs online [database on the Internet]. Hudson (OH): Lexi-Comp, Inc.; 2019. Available from: http://online.lexi.com (Accessed on 19 Jan 2022).
- Bairam A, Uppari N, Mubayed S, Joseph V. An overview on the respiratory stimulant effects of caffeine and progesterone on response to hypoxia and apnea frequency in developing rats. Adv Exp Med Biol. 2015;860:211-20.
- Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281.
- Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience. 2003;4(5):399–415.
- Feeney D. M., Baron J. C. Diaschisis. Stroke. 1986;17(5):817– 830.
- Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology. 2018;128:102737.
- Stanley NN, Galloway JM, Flint KC, Campbell DB. Increased respiratory chemosensitivity in patients with chronic airways obstruction. Br J Dis Chest. 1983;77:136-46.
- Gaudy JH, Dauthier C, Fourgeaux B. Effect of a new analeptic drug, almitrine, on fentanyl-induced respiratory depression and analgesia in man. Br J Anaesth. 1982;54:617-21.
- European Medicines Agency Communication: Oral almitrine to be withdrawn by EU member states. EMEA/313994, 2013. [updated 2013 May 31; cited 2022 Feb 9]. Available from:www. ema.europa.eu/ema/index.jsp?curl=pages/medicines/ human/referrals/Almitrine/human_referral_prac_000011. jsp&mid=WC0b01ac05805c516f.
- Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6.
- Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lotsch J. The partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine induced respiratory depression in humans. Clin Pharmacol Ther. 2007;81:59-68.
- Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol. 2006;6:82-88.
- Oertel BG, Felden L, Tran PV, Bradshaw MH, Angst MS, Schmidt H, Johnson S, Greer JJ, Geisslinger G, Varney MA, Lötsch J. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther. 2010;87(2):204-11.
- Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology. 1975;42:559-66.
- Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6.
- Gairola RL, Gupta PK, Pandley K. Antagonists of morphine induced respiratory depression: a study in postoperative patients. Anaesthesia. 1980;35:17-21.
- Roozekrans M, Olofsen E, van der Schrier R, Boom M, Mooren R, Dahan A. Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations. A PK-PD/PK-PD modeling study in healthy volunteers. Clin Pharmacol Ther. 2017;102:115-22.
- Stephen CR, Talton I. Investigation of doxapram as a postanesthetic respiratory stimulant. Anesthesia & Analgesia. 1964;43:628-40.
- Abelson JL, Nesse RM, Weg JG, Curtis GC. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosomatic Medicine. 1996a;58:302-13.
- Abelson JL, Weg JG, Nesse RM, Curtis GC. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology. 1996b;21:375-90.
- Miyata M, Hata T, Kato N, Takeuchi M, Mizutani H, Kubota M, Yamazaki T. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride. Journal of Perinatal Medicine. 2007;35.
- Jonkman K, van Rijnsoever E, Olofsen E, et al. Esketamine counters opioid-induced respiratory depression. Br J Anaesth. 2018;120(5):1117-27.
- McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, Rowe IC. A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Caactivated K (BK) channel alpha-subunits. Proc Natl Acad Sci USA. 2005;102:17870-6.
- Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology. 2014;121:459-68.
- Roozekrans M, Olofsen E, van der Schrier R, van Gerven J, Peng S, McLeod J, Dahan A. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokineticpharmacodynamic modeling study in healthy volunteers. Clin Pharmacol Ther. 2015;97:641-9.
Language: English
Page range: 49 - 54
Submitted on: Jul 14, 2022
Accepted on: Dec 27, 2022
Published on: Feb 8, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2023 Pei Ling Tan, Chuan Poh Lim, Sharon Ong, Geoffrey Sithamparapillai Samuel, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.